FDA - Food and Drug Administration

20/11/2024 | Press release | Distributed by Public on 20/11/2024 18:54

Umary (UMARY Hyaluronic Acid tablets/MXBBB) Recall reason: The product contains undeclared diclofenac and omeprazole

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.